Journal
CLINICAL AND TRANSLATIONAL ALLERGY
Volume 4, Issue -, Pages -Publisher
BMC
DOI: 10.1186/2045-7022-4-41
Keywords
Schnitzler's syndrome; Interleukin-1 beta; Autoinflammation; Chronic urticaria; Paraprotein; Monoclonal gammopathy
Categories
Funding
- Novartis
- SOBI
Ask authors/readers for more resources
Schnitzler's syndrome is an autoinflammatory disorder characterized by the association of a monoclonal IgM (or IgG) gammopathy, a chronic urticarial rash, and signs and symptoms of systemic inflammation, including fever, arthralgias and bone pain. It was first described in 1972. This review summarizes the clinical features, efficacy of therapies, and follow-up data of the 281 cases that have been reported to date. Also, the results of skin histology, bone imaging, laboratory investigations, and studies of the pathogenesis will be discussed, including the pivotal role of interleukin-1 beta in this disorder.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available